| __timestamp | Dr. Reddy's Laboratories Limited | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 3788000000 |
| Thursday, January 1, 2015 | 62786000000 | 4006000000 |
| Friday, January 1, 2016 | 62427000000 | 4261000000 |
| Sunday, January 1, 2017 | 62453000000 | 4371000000 |
| Monday, January 1, 2018 | 65724000000 | 4853000000 |
| Tuesday, January 1, 2019 | 70421000000 | 4675000000 |
| Wednesday, January 1, 2020 | 80591000000 | 4572000000 |
| Friday, January 1, 2021 | 86645000000 | 6601000000 |
| Saturday, January 1, 2022 | 100551000000 | 5657000000 |
| Sunday, January 1, 2023 | 42907000000 | 6498000000 |
| Monday, January 1, 2024 | 115557000000 | 28675800000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. From 2014 to 2023, Dr. Reddy's Laboratories Limited consistently outpaced Gilead Sciences, Inc. in terms of cost of revenue. Dr. Reddy's saw a remarkable 105% increase, peaking in 2024, while Gilead's costs remained relatively stable, with a modest 72% rise by 2023. Notably, Dr. Reddy's costs surged in 2024, reaching a new high, though data for Gilead in 2024 is unavailable. This trend highlights Dr. Reddy's aggressive expansion and market penetration strategies. Meanwhile, Gilead's steady cost management reflects its focus on optimizing operational efficiencies. These insights offer a glimpse into the strategic priorities of these pharmaceutical giants, providing valuable lessons for investors and industry analysts alike.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs Gilead Sciences, Inc.
Gilead Sciences, Inc. vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Gilead Sciences, Inc. vs Veracyte, Inc.
Cost Insights: Breaking Down Gilead Sciences, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue: Key Insights for Gilead Sciences, Inc. and Iovance Biotherapeutics, Inc.
Cost of Revenue Trends: Gilead Sciences, Inc. vs Geron Corporation
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Travere Therapeutics, Inc.
Cost of Revenue Trends: Gilead Sciences, Inc. vs MiMedx Group, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.